Dynavax to Present at the H.C. Wainwright Virtual Fireside Chat Series

Rhea-AI Summary

Dynavax Technologies Corporation (Nasdaq: DVAX) announced that CEO Ryan Spencer will participate in a virtual fireside chat at the H.C. Wainwright Virtual Fireside Chat Series on June 25, 2020, at 10:50 a.m. E.T. Interested parties can access the presentation through the 'Events & Presentations' section on Dynavax's investor website. Dynavax is focused on developing and commercializing novel vaccines, including HEPLISAV-B®, a Hepatitis B vaccine. The company is also advancing its CpG 1018 adjuvant for COVID-19 and pertussis vaccines. For more details, visit www.dynavax.com.

EMERYVILLE, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that Ryan Spencer, Chief Executive Officer, will participate in a virtual fireside chat at the H.C. Wainwright Virtual Fireside Chat Series on Thursday, June 25, at 10:50 a.m. E.T.

The presentation will be webcast and may be accessed through the “Events & Presentations” page on the “investors” section of the Company’s website at http://investors.dynavax.com/events-presentations.

About Dynavax
Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company launched its first commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], in February 2018, following U.S. FDA approval for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older.  Dynavax is also further developing CpG 1018 as an advanced vaccine adjuvant through research collaborations and partnerships.  Current collaborations are focused on adjuvanted vaccines for COVID-19 and pertussis.  For more information, visit www.dynavax.com and follow the company on LinkedIn.

Contacts:

Nicole Arndt
narndt@dynavax.com
510-665-7264

Derek Cole, President
Investor Relations Advisory Solutions
derek.cole@IRadvisory.com

FAQ

When will Ryan Spencer participate in the virtual fireside chat for Dynavax (DVAX)?

Ryan Spencer will participate in the virtual fireside chat on June 25, 2020, at 10:50 a.m. E.T.

How can I watch the Dynavax (DVAX) fireside chat online?

The presentation can be accessed on the 'Events & Presentations' page in the investors section of Dynavax's website.

What is the main focus of Dynavax Technologies Corporation (DVAX)?

Dynavax is focused on developing and commercializing novel vaccines, including Hepatitis B and advanced vaccine adjuvants.

What product did Dynavax launch in February 2018?

Dynavax launched HEPLISAV-B®, a Hepatitis B vaccine, in February 2018.

What collaborations is Dynavax (DVAX) currently involved in?

Dynavax is collaborating on adjuvanted vaccines for COVID-19 and pertussis.